Now is the time to get those cards you might have missed from the First Chapter and Floodborn, as well as some special packs.

The endorsement means the EMA will offer Carthera support and advice as it moves towards a regulatory filing for its ...

Enrollment in company’s first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for ...

Production on season two of the prequel series begins today in Scotland. The post Outlander: Blood of my Blood Renewed Ahead ...

The blood cancer multiple myeloma is deadly. This disease is personal for us because one of our best friends and colleagues ...

About Hereditary Hemorrhagic Telangiectasia (HHT) ‍HHT is a rare disease that affects more than 150,000 people in the U.S. and EU, and for which there are currently no approved therapies. In HHT, loss ...

Diagonal’s First-in-Class Clustering Antibody, DIAG723, Receives Orphan Drug Designation (ODD) from U.S. FDA and an ODD Positive Opinion from EMA for Treatment of Hereditary Hemorrhagic ...

‍HHT is a rare disease that affects more than 150,000 people in the U.S. and EU, and for which there are currently no approved therapies. In HHT, loss-of-function point mutations in members of the TGF ...

The FDA has granted Mesoblast’s stem cell therapy, Ryoncil (remestemcel-L), seven years of orphan drug exclusivity for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD) in ...

Aged just three, covered in her dead father’s blood, Abigail was taken by Hamas. She turned four as an orphaned hostage. Now, at five, she is free, smiling, dancing. Until she hears a car ...